ARTL - Artelo Biosciences - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ARTL is currently covered by 2 analysts with an average price target of $42.26. This is a potential upside of $28.5 (207.12%) from yesterday's end of day stock price of $13.76.

Artelo Biosciences's activity chart (see below) currently has 3 price targets and 22 ratings on display. The stock rating distribution of ARTL is 93.75% BUY and 6.25% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 47.5% with an average time for these price targets to be met of 108.75 days.

Highest price target for ARTL is $20, Lowest price target is $5, average price target is $12.5.

Most recent stock forecast was given by JASON KOLBERT from D. BORAL CAPITAL on 08-Jul-2025. First documented stock forecast 12-Feb-2021.

Best performing analysts who are covering ARTL - Artelo Biosciences:

Jason Kolbert Vernon Bernardino Jason Mccarthy Michael Higgins

Currently out of the existing stock ratings of ARTL, 15 are a BUY (93.75%), 1 are a HOLD (6.25%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$20

$5.05 (33.78%)

16 days ago
(08-Jul-2025)

7/7 (100%)

$4.1 (25.79%)

63

Buy

$5

$-9.95 (-66.56%)

$5

4 months 20 days ago
(04-Mar-2025)

9/10 (90%)

$3.93 (367.29%)

372

Buy

$105

2 years 3 months 21 days ago
(03-Apr-2023)

0/1 (0%)

$65.1 (163.16%)

Buy

$75

$71.79 (2236.45%)

$120

4 years 5 months 7 days ago
(17-Feb-2021)

0/2 (0%)

$40.88 (71.42%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ARTL (Artelo Biosciences) average time for price targets to be met?

On average it took 108.75 days on average for the stock forecasts to be realized with a an average price target met ratio 47.5

Which analyst has the current highest performing score on ARTL (Artelo Biosciences) with a proven track record?

JASON KOLBERT

Which analyst has the current lower performing score on ARTL (Artelo Biosciences) with a proven track record?

MICHAEL HIGGINS

Which analyst has the most public recommendations on ARTL (Artelo Biosciences)?

Jason Kolbert has 5 price targets and 12 ratings on ARTL

Which analyst is the currently most bullish on ARTL (Artelo Biosciences)?

Jason Mccarthy with highest potential upside - $71.79

Which analyst is the currently most reserved on ARTL (Artelo Biosciences)?

Vernon Bernardino with lowest potential downside - -$9.95

Artelo Biosciences in the News

Artelo Biosciences Announces Positive Preclinical Efficacy with ART12.11 in Stress-Induced Depression Model

ART12.11, the Patented CBD:TMP Cocrystal, Demonstrates Potent Antidepressant-Like Activity and Cognitive Benefits Over Leading SSRI Data Being Presented at the 35th Annual International Cannabinoid Research Society Symposium SOLANA BEACH, Calif., July 07, 2025 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?